These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17672493)

  • 21. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
    Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
    Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization, DNA binding and catalytic applications of Ru(III) complexes.
    Shoair AF; El-Shobaky AR; Azab EA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015; 151():322-34. PubMed ID: 26143325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between DNA purines and ruthenium ammine complexes within nanostructured sol-gel silica matrixes.
    Lopes LM; Garcia AR; Brogueira P; Ilharco LM
    J Phys Chem B; 2010 Mar; 114(11):3987-98. PubMed ID: 20196584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenanthroline ligands are biologically more active than their corresponding ruthenium(II) arene complexes.
    Valladolid J; Hortigüela C; Busto N; Espino G; Rodríguez AM; Leal JM; Jalón FA; Manzano BR; Carbayo A; García B
    Dalton Trans; 2014 Feb; 43(6):2629-45. PubMed ID: 24327227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bifunctional amine-tethered ruthenium(II) arene complexes form monofunctional adducts on DNA.
    Melchart M; Habtemariam A; Novakova O; Moggach SA; Fabbiani FP; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2007 Oct; 46(21):8950-62. PubMed ID: 17850143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex.
    Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ
    Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactivity of the antitumor complex (H2trz)[trans-RuCl4(N2-Htrz)2] in the presence of DNA purines within a fluorinated silica matrix.
    Lopes LM; Kopylovich MN; Pombeiro AL; Ilharco LM
    J Phys Chem B; 2012 Jan; 116(3):1189-99. PubMed ID: 22188554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
    Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
    Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA interactions of dinuclear RuII arene antitumor complexes in cell-free media.
    Nováková O; Nazarov AA; Hartinger CG; Keppler BK; Brabec V
    Biochem Pharmacol; 2009 Feb; 77(3):364-74. PubMed ID: 19014908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similar binding of the carcinostatic drugs cis-[Pt(NH3)2Cl2] and [Ru(NH3)5Cl] Cl2 to tRNAphe and a comparison with the binding of the inactive trans-[Pt(NH3)2Cl2] complex - reluctance in binding to Watson-Crick base pairs within double helix.
    Rubin JR; Sabat M; Sundaralingam M
    Nucleic Acids Res; 1983 Sep; 11(18):6571-86. PubMed ID: 6353373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inert benzothiazole functionalised ruthenium(II) complexes; potential DNA hairpin binding agents.
    Spillane CB; Morgan JL; Fletcher NC; Collins JG; Keene FR
    Dalton Trans; 2006 Jul; (25):3122-33. PubMed ID: 16786071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence emission and polarization for analyzing binding of ruthenium metalloglycocluster to lectin and tetanus toxin C-fragment.
    Okada T; Makino T; Minoura N
    Bioconjug Chem; 2009 Jul; 20(7):1296-8. PubMed ID: 19537755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic recognition of AT-rich DNA by ruthenium complexes.
    Nordell P; Westerlund F; Wilhelmsson LM; Nordén B; Lincoln P
    Angew Chem Int Ed Engl; 2007; 46(13):2203-6. PubMed ID: 17310483
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New [Ru(5,6-dmp/3,4,7,8-tmp)₂(diimine)]²⁺ complexes: non-covalent DNA and protein binding, anticancer activity and fluorescent probes for nuclear and protein components.
    Rajendiran V; Palaniandavar M; Periasamy VS; Akbarsha MA
    J Inorg Biochem; 2012 Nov; 116():151-62. PubMed ID: 23022692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insights into the binding sites of organometallic ruthenium anticancer compounds on peptides using ultra-high resolution mass spectrometry.
    Wills RH; Habtemariam A; Lopez-Clavijo AF; Barrow MP; Sadler PJ; O'Connor PB
    J Am Soc Mass Spectrom; 2014 Apr; 25(4):662-72. PubMed ID: 24488754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
    Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
    Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.
    Ekengard E; Glans L; Cassells I; Fogeron T; Govender P; Stringer T; Chellan P; Lisensky GC; Hersh WH; Doverbratt I; Lidin S; de Kock C; Smith PJ; Smith GS; Nordlander E
    Dalton Trans; 2015 Nov; 44(44):19314-29. PubMed ID: 26491831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.